Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

A well-known XRP trader who famously predicted the token's explosive rally to $3 is now turning heads with a bold new forecast—this time for an emerging AI toke ...